Hematological toxicity is the most common and the most frequent fatal complication of chemotherapy. It is observed with increased frequency with age, it is a significant independent predictor of the development of febrile neutropenia, and may contribute to a reluctance to administer chemotherapy in the elderly patient population. The authors analyze published data on effectiveness and results of the use of colony stimulating factors for preventing and treating elderly patients affected by tumors during chemotherapy. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
The use of colony stimulating factors in elderly patients with cancer / M., Pietropaolo; W., Gianni; SILI SCAVALLI, Antonio; Marigliano, Vincenzo; L., Repetto. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - STAMPA. - 48:S(2003), pp. S33-S37. (Intervento presentato al convegno Workshop on Geriatric Oncology: Focus on Myelodepression tenutosi a SYRACUSE, ITALY nel SEP 13, 2002) [10.1016/j.critrevonc.2003.06.002].
The use of colony stimulating factors in elderly patients with cancer
SILI SCAVALLI, Antonio;MARIGLIANO, Vincenzo;
2003
Abstract
Hematological toxicity is the most common and the most frequent fatal complication of chemotherapy. It is observed with increased frequency with age, it is a significant independent predictor of the development of febrile neutropenia, and may contribute to a reluctance to administer chemotherapy in the elderly patient population. The authors analyze published data on effectiveness and results of the use of colony stimulating factors for preventing and treating elderly patients affected by tumors during chemotherapy. (C) 2003 Elsevier Ireland Ltd. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
